ALNA Market Cap History



Below is a table of the ALNA market cap history going back to 11/2/2017:

Date ALNA Market Cap
11/2/2017205.81M
12/11/2017307.78M
3/1/2018130.38M
4/27/2018308.78M
8/1/2018217.69M
11/1/2018176.47M
3/1/2019142.17M
4/26/2019136.35M
7/26/201994.57M
4/30/2018569.40M
11/1/2019129.30M
3/6/202043.79M
4/10/202028.45M
5/1/202036.87M
7/31/202047.27M
11/2/202048.63M
3/5/202183.61M
5/7/202166.34M
8/6/202176.13M
11/5/202180.75M
3/25/202222.17M
4/25/202217.33M
5/9/202210.56M
8/12/202214.77M

Also see: ALNA Shares Outstanding History
and ALNA YTD Return
ALNA Historical Market Cap:
-42.38% CAGR
ALNA Historical Market Cap: +-42.38% CAGR

Mouse over chart for data details
11/2/2017 ...8/12/2022
Allena Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing oral enzyme therapeutics to treat patients with metabolic and kidney disorders. Co. is focused on metabolic disorders that result in excess accumulation of certain metabolites that stimulate inflammation, damage the kidney, and potentially lead to chronic kidney disease (CKD), and end-stage renal disease. Co.'s product candidate, ALLN-346, is an orally administered, urate degrading enzyme for patients with hyperuricemia and gout in the setting of improved CKD. Co. has conducted a Phase 1 program, including both a single-ascending dose and multiple-ascending dose study in healthy volunteers. We show 24 historical shares outstanding datapoints in our ALNA shares outstanding history coverage, used to compute ALNA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALNA market cap history over the course of time is important for investors interested in comparing ALNA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALNA versus a peer is one thing; comparing ALNA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALNA can fluctuate over the course of history. With this page we aim to empower investors researching ALNA by allowing them to research the ALNA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Allena Pharmaceuticals (ALNA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALNY Market Cap History
ALOG Market Cap History
ALPN Market Cap History
ALQA Market Cap History
ALRN Market Cap History
ALT Market Cap History
ALVR Market Cap History
ALXN Market Cap History
ALXO Market Cap History
ALZN Market Cap History
More Healthcare companies »

 

ALNA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.